Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for human IDH2
Most Correlated Studies
- L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
- L1000 CMAP Lung cancer NCI-H1299 cells with gene overexpression perturbations
- L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
- L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
- L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Most Relevant Literature
- Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Glioma…
- Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.
- Crystal structures of pan-IDH inhibitor AG-881 in complex with mutant human IDH1 and IDH2.
- Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer.
- T cells take aim in AML: targeting IDH2.
Most Relevant Clinical Trials
- Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
- Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene…
- A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukem…
- Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutatio…
